Ovarian steroid cell tumor, not otherwise specified

Area of Science:

• Gynecologic Oncology
• Endocrinology
• Pathology

Background:

• Ovarian steroid cell tumors are rare, virilizing neoplasms characterized by steroid cell proliferation.
• These tumors include Leydig cell tumors, steroid cell tumors Not Otherwise Specified (NOS), and stromal luteomas.
• While often benign, steroid cell tumors NOS can exhibit malignant behavior.

Observation:

• A 36-year-old female presented with weight loss, amenorrhea, and hirsutism.
• Elevated serum testosterone levels (150 ng/ml) were noted, with normal levels for CA 125, Inhibin A, Inhibin B, FSH, LH, and prolactin.
• Histopathological features described by Hayes and Scully can indicate malignant potential.

Findings:

• The case involved a steroid cell tumor, NOS, presenting with significant virilization.
• Diagnostic challenges include differentiating it from Leydig cell tumors and other malignancies like clear cell carcinoma or adrenocortical tumors.
• Lack of cytoplasmic Reinke's crystals is a key differentiator from Leydig cell tumors.

Implications:

• Accurate histopathological assessment is vital for distinguishing benign from malignant steroid cell tumors NOS.
• Timely diagnosis and appropriate management are essential for patients with these rare ovarian neoplasms.
• Further research into the specific histopathological markers for malignancy in steroid cell tumors NOS is warranted.